On the mechanism of antidepressant-like action of berberine chloride

European Journal of Pharmacology

Volumn 589, Issue 1-3, 2008, Pages 163-172

  Kulkarni, Shrinivas K ^a   Dhir, Ashish ^a  

^a PANJAB UNIVERSITY   (India)

Author keywords

Antidepressant; Berberine chloride; Monoamines; Nitric oxide; Sigma receptors

Indexed keywords

7 NITROINDAZOLE; ADRENALIN; ANTIDEPRESSANT AGENT; ARGININE; BARBITURIC ACID DERIVATIVE; BERBERINE; DOPAMINE; FLUOXETINE; IMIPRAMINE; METHYLENE BLUE; N [2 (3,4 DICHLOROPHENYL)ETHYL] 2 DIMETHYLAMINO N METHYLETHYLAMINE; NORADRENALIN; PENTAZOCINE; PROGESTERONE; RESERPINE; RIMCAZOLE; SEROTONIN; SILDENAFIL; TRANYLCYPROMINE; VENLAFAXINE;

ADRENALIN BLOOD LEVEL; ANIMAL BEHAVIOR; ANIMAL EXPERIMENT; ANTINOCICEPTION; ARTICLE; CONTROLLED STUDY; DOPAMINE BLOOD LEVEL; DOSE RESPONSE; DRUG ACTIVITY; DRUG EFFECT; DRUG MECHANISM; DRUG POTENTIATION; FORCED SWIMMING TEST; LOCOMOTION; MALE; MOUSE; NONHUMAN; NORADRENALIN BLOOD LEVEL; PRIORITY JOURNAL; SEROTONIN BLOOD LEVEL;

ANALGESICS; ANIMALS; ANTIDEPRESSIVE AGENTS; BEHAVIOR, ANIMAL; BERBERINE; BODY TEMPERATURE; BRAIN; DEPRESSION; DISEASE MODELS, ANIMAL; DOPAMINE; DOSE-RESPONSE RELATIONSHIP, DRUG; DRUG INTERACTIONS; DRUG THERAPY, COMBINATION; HEAT; MALE; MICE; MOTOR ACTIVITY; NITRIC OXIDE; NOREPINEPHRINE; PAIN; PAIN MEASUREMENT; PAIN THRESHOLD; RATS; RATS, WISTAR; RECEPTORS, SIGMA; RESERPINE; SEROTONIN; SLEEP; SWIMMING; TIME FACTORS; UP-REGULATION;

EID: 47549086101     PISSN: 00142999     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.ejphar.2008.05.043     Document Type: Article

References (63)

1. Almeida R.C., Felisbino C.S., Lopez M.G., Rodrigues A.L.S., and Gabilan N.H. Evidence for the involvement of l-arginine-nitric oxide-cyclic guanosine monophosphate pathway in the antidepressant-like effect of memantine in mice. Behav. Brain Res. 168 (2006) 318-322
2. Bermack J.E., and Debonnel G. The role of sigma receptors in depression. J. Pharmacol. Sci. 97 (2005) 317-336
3. Beyer C.E., Boikess S., Luo B., and Dawson L.A. Comparison of the effects of antidepressants on norepinephrine and serotonin concentrations in the rat frontal cortex, an in-vivo microdialysis study. J. Psychopharmacol. 16 (2002) 297-304
4. Birdsall T.C., and Kelly G.S. Berberine, Therapeutic potential of an alkaloid found in several medicinal plants. Altern. Med. Rev. 2 (1997) 94-103
5. Bryant S.G., and Brown C.S. Current concepts in clinical therapeutics, major affective disorders. Clin. Pharm. 5 (1986) 385-395
6. Chang H.M., and But P.P.H. Pharmacology and Applications of Chinese Materia Medica (1986), World Scientific, Singapore
7. Dhir A., and Kulkarni S.K. Involvement of nitric oxide NO signaling pathway in the antidepressant action of bupropion, a dopamine reuptake inhibitor. Eur. J. Pharmacol. 568 (2007) 177-185
8. 1 receptor modulation in the antidepressant action of venlafaxine. Neurosci. Lett. 420 (2007) 204-208
9. 1 receptors in modulating the antidepressant effect of neurosteroids dehydroepiandrosterone or pregnenolone in mouse tail-suspension test. J. Psychopharmacol. 28 (2008) Feb
10. Dhir A., Naidu P.S., and Kulkarni S.K. Protective effect of cyclooxygenase-2 COX-2 inhibitors but not non-selective cyclooxygenase COX-inhibitors on ethanol withdrawal-induced behavioural changes. Addict. Biol. 10 (2005) 329-335
11. Esplugues J.V. NO as a signalling molecule in the nervous system. Brit. J. Pharmacol. 135 (2002) 1079-1095
12. Harkin A., Connor T.J., Walsh M., St John N., and Kelly J.P. Serotonergic mediation of the antidepressant-like effects of nitric oxide synthase inhibitors. Neuropharmacology 44 (2003) 616-623
13. Harkin A., Connor T.J., Burns M.P., and Kelly J.P. Nitric oxide inhibitors augment the effects of serotonin re-uptake inhibitors in the forced swimming test. Eur. Neuropsychopharmacol. 14 (2004) 274-281
14. Hashimoto K., and Ishiwata K. Sigma receptor ligands, possible application as therapeutic drugs and as radiopharmaceuticals. Curr. Pharm. Des. 12 (2006) 3857-3876
15. Heiberg I.L., Wegener G., and Rosenberg R. Reduction of cGMP and nitric oxide has antidepressant-like effects in the forced swimming test in rats. Behav. Brain. Res. 134 (2002) 479-484
16. Heroux J.A., Tam S.W., and De Souza E.B. Autoradiographic identification and characterization of sigma receptors in guinea pig brain using [3H]1cyclopropylmethyl-4-2′-4″-fluorophenyl-2′-oxoethyl piperidine [3H]DuP 734, a novel sigma receptor ligand. Brain Res. 598 (1992) 76-86
17. Huang C.G., Chu Z.L., and Yang Z.M. Effects of berberine on synthesis of platelet TXA2 and plasma PGI2 in rabbits. Chung Kuo Yao Li Hsueh Pao 12 (1991) 526-528
18. Ingkaninan K., Phengpa P., Yuenyongsawad S., and Khorana N. Acetylcholinesterase inhibitors from Stephania venosa tuber. J. Pharm. Pharmacol. 58 (2006) 695-700
19. Ishihara K., and Sasa M. Modulation of neuronal activities in the central nervous system via sigma receptors. Nihon Shinkei Seishin Yakurigaku Zasshi 22 (2002) 23-30
20. Joca S.R., and Guimaraes F.S. Inhibition of neuronal nitric oxide synthase in the rat hippocampus induces antidepressant-like effects. Psychopharmacology 185 (2006) 298-305
21. Kanazawa I. Short review on monoamine oxidase and its inhibitors. Eur. Neurol. 34 (1994) 36-39
22. Kaster M.P., Ferreira P.K., Santos A.R.S., and Rodrigues A.L.S. Effect of potassium channel inhibitors in the forced swimming test, possible involvement of l-arginine-nitric oxide-soluble guanylate cyclase pathway. Behav. Brain. Res. 165 (2005) 204-209
23. Kinsora J.J., Corbin A., Snider B., Wiley J., Meltzer L., and Heffner T. Effects of igmesine in preclinical antidepressant tests. Soc. Neurosci. 24 (1998) 744
24. Kitaichi K., Chabot J.G., Moebius F.F., Flandorfer A., Glossmann H., and Quirion R. Expression of the purported sigma1 receptor in the mammalian brain and its possible relevance in deficits induced by antagonism of the NMDA receptor complex as revealed using an antisense strategy. J. Chem. Neuroanat. 20 (2000) 375-387
25. Kobayashi T., Matsuno K., Murai M., and Mita S. Sigma 1 receptor subtype is involved in the facilitation of cortical dopaminergic transmission in the rat brain. Neurochem. Res. 22 (1997) 1105-1109
26. Kong L.D., Cheng C.H., and Tan R.X. Monoamine oxidase inhibitors from rhizoma of Coptis chinensis. Planta Med. 67 (2001) 74-76
27. Kong W., Wei J., Abidi P., Lin M., Inaba S., Li C., Wang Y., Wang Z., Si S., Pan H., Wang S., Wu J., Wang Y., Li Z., Liu J., and Jiang J.D. Berberine is a novel cholesterol-lowering drug working through a unique mechanism distinct from statins. Nat. Med. 10 (2004) 1344-1351
28. Kulkarni S.K. Heat and other physiological stress-induced analgesia, catecholamine mediated and naloxone reversible response. Life Sci. 27 (1980) 185-188
29. Kulkarni S.K. Experiments on Intact Preparation. 3rd Edition (1999), Vallabh Prakashan, Delhi 123-124
30. Kulkarni S.K., and Mehta A.K. Purine nucleoside-mediated immobility in mice, reversal by antidepressants. Psychopharmacology 85 (1985) 460-463
31. Kulkarni S.K., and Dhir A. Effect of various classes of antidepressants in behavioural paradigms of despair. Prog. Neuropsychopharmacol. Biol. Psychiatry. 31 (2007) 1248-1254
32. Kulkarni S.K., Dandiya P.C., and Varandani N.L. Pharmacological investigations of berberine sulphate. Jpn. J. Pharmacol. 22 (1972) 11-16
33. Lee Y.S., Kim W.S., Kim K.H., Yoon M.J., Cho H.J., Shen Y., Ye J.M., Lee C.H., Oh W.K., Kim C.T., Hohnen-Behrens C., Gosby A., Kraegen E.W., James D.E., and Kim J.B. Berberine, a natural plant product, activates AMP-activated protein kinase with beneficial metabolic effects in diabetic and insulin-resistant states. Diabetes 55 (2006) 2256-2264
34. Mantovani M., Pertile R., Calixto J.B., Santos A.R., and Rodrigues A.L. Melatonin exerts an antidepressant-like effect in the tail suspension test in mice, evidence for involvement of N-methyl-d-aspartate receptors and the l-arginine-nitric oxide pathway. Neurosci. Lett. 343 (2003) 1-4
35. Matsuno K., Kobayashi T., Tanaka M.K., and Mita S. Sigma 1 receptor subtype is involved in the relief of behavioral despair in the mouse forced swimming test. Eur. J. Pharmacol. 312 (1996) 267-271
36. 2 dopamine receptor mediation and absence of spare receptors. Pharmacol. Biochem. Behav. 32 (1989) 141-145
37. Narita N., Hashimoto K., Tomitaka S., and Minabe Y. Interactions of selective serotonin reuptake inhibitors with subtypes of sigma receptors in rat brain. Eur. J. Pharmacol. 307 (1996) 117-119
38. Pan L.R., Tan Q., Fu Q., Hu B.R., Xiang J.Z., and Qian J.Q. Roles of nitric oxide in protective effect of berberine in ethanol-induced gastric ulcer mice. Acta Pharmacol. Sin 26 (2005) 1334-1338
39. Parale M.P., and Kulkarni S.K. Clonidine-induced behavioural despair in mice, reversal by antidepressants. Psychopharmacology 89 (1986) 171-174
40. Patil C.S., Singh V.P., and Kulkarni S.K. Peripheral and central activation of nitric oxide-cyclic GMP pathway by sildenafil. Inflammopharmacology 13 (2005) 467-478
41. Peng W.H., Wu C.R., Chen C.S., Chen C.F., Leu Z.C., and Hsieh M.T. Anxiolytic effect of berberine on exploratory activity of the mouse in two experimental anxiety models, interaction with drugs acting at 5-HT receptors. Life Sci. 75 (2004) 2451-2462
42. Peng W.H., Lo K.L., Lee Y.H., Hung T.H., and Lin Y.C. Berberine produces antidepressant-like effects in the forced swim test and in the tail suspension test in mice. Life Sci. 81 (2007) 933-938
43. Porsolt R.D., Anton G., Blavet N., and Jalfre M. Behavioural despair in rats, a new model sensitive to antidepressant treatments. Eur. J. Pharmacol. 47 (1978) 379-391
44. Rabbani G.H., Butler T., Knight J., Sanyal S.C., and Alam K. Randomized controlled trial of berberine sulfate therapy for diarrhea due to enterotoxigenic Escherichia coli and Vibrio cholerae. J. Infect. Dis. 155 (1987) 979-984
45. Reddy D.S., Kaur G., and Kulkarni S.K. Sigma 1 receptor mediated anti-depressant-like effects of neurosteroids in the Porsolt forced swim test. Neuroreport 9 (1998) 3069-3073
46. Rogoz Z., and Skuza G. Mechanism of synergistic action following co-treatment with pramipexole and fluoxetine or sertraline in the forced swimming test in rats. Pharmacol. Rep. 58 (2006) 493-500
47. Shaji A.V., and Kulkarni S.K. Central nervous system depressant activities of melatonin in rats and mice. Indian J. Exp. Biol. 36 (1988) 257-263
48. Sharma A., and Kulkarni S.K. Dopamine receptor mediated antidepressant action of B-HT 920 in mice. Indian J. Exp. Biol. 32 (1994) 172-175
49. Skuza G., and Rogoz Z. Sigma1 receptor antagonists attenuate antidepressant-like effect induced by co-administration of 1,3 di-o-tolylguanidine (DTG) and memantine in the forced swimming test in rats. Pol. J. Pharmacol. 55 (2003) 1149-1152
50. Skuza G., and Rogoz Z. The synergistic effect of selective sigma receptor agonists and uncompetitive NMDA receptor antagonists in the forced swim test in rats. J. Physiol. Pharmacol. 57 (2006) 217-229
51. Stahl S.M. Antidepressant treatment of psychotic major depression, potential role of the sigma receptor. CNS Spectr. 10 (2005) 319-323
52. Steru L., Chermat R., Thierry B., and Simon P. The tail suspension test, a new method for screening antidepressants in mice. Psychopharmacology 85 (1985) 367-370
53. Su T.P., and Hayashi T. Understanding the molecular mechanism of sigma1 receptors, towards a hypothesis that sigma1 receptors are intracellular amplifiers for signal transduction. Curr. Med. Chem. 10 (2003) 2073-2080
54. Takebayashi M., Hayashi T., and Su T.P. A perspective on the new mechanism of antidepressants, neuritogenesis through sigma1 receptors. Pharmacopsychiatry 37 (2004) S208-S213
55. Ukai M., Maeda H., Nanya Y., Kameyama T., and Matsuno K. Beneficial effects of acute and repeated administrations of sigma receptor agonists on behavioral despair in mice exposed to tail suspension. Pharmacol. Biochem. Behav. 61 (1998) 247-252
56. Verma A., and Kulkarni S.K. Chronic electroconvulsive shock alters hypothermic response of B-HT 920 and SKF 38393 in rats. J. Pharm. Pharmacol. 43 (1991) 813-814
57. Wang J., Mack A.L., Coop A., and Matsumoto R.R. Novel sigma receptor agonists produce antidepressant-like effects in mice. Eur. Neuropsychopharmacol. 17 (2007) 708-716
58. Wegener G., Volke V., Harvey B.H., and Rosenberg R. Local, but not systemic, administration of serotonergic antidepressants decreases hippocampal nitric oxide synthase activity. Brain Res. 959 (2003) 128-134
59. Yagasaki Y., Numakawa T., Kumamaru E., Hayashi T., Su T.P., and Kunugi H. Chronic antidepressants potentiate via sigma1 receptors the brain-derived neurotrophic factor-induced signaling for glutamate release. J. Biol. Chem. 281 (2006) 12941-12949
60. Yanxia N. Therapeutic effect of berberine on 60 patients with type II diabetes mellitus and experimental research. Zhong Xi Yi Jie He Za Zhi 8 (1988) 711-713
61. Yoo K.Y., Hwang I.K., Lim B.O., Kang T.C., Kim D.W., Kim S.M., Lee H.Y., Kim J.D., and Won M.H. Berberry extract reduces neuronal damage and N-methyl-d-aspartate receptor 1 immunoreactivity in the gerbil hippocampus after transient forebrain ischemia. Biol. Pharm. Bull. 29 (2006) 623-628
62. Zeng X.H., Zeng X.J., and Li Y.Y. Efficacy and safety of berberine for congestive heart failure secondary to ischemic or idiopathic dilated cardiomyopathy. Am. J. Cardiol. 92 (2003) 173-176
63. Zhu F., and Qian C. Berberine chloride can ameliorate the spatial memory impairment and increase the expression of interleukin-1beta and inducible nitric oxide synthase in the rat model of Alzheimer's disease. BMC Neuroscience 7 (2006) 78